| Financial Year |
March 31 2023 |
| Monetary Funds |
59,348,624.44 |
| Held-for-trading Financial Assets |
124,969,531.33 |
| Notes Receivable |
-- |
| Accounts Receivable |
169,665,316.77 |
| Advances to Suppliers |
10,945,256.56 |
| Other Receivables |
1,383,447.12 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
220,507,795.55 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,287,165.50 |
| Total Current Assets |
589,107,137.27 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
631,105.42 |
| Fixed Assetes |
255,353,964.80 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
54,261,434.12 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
5,215,843.05 |
| Deferred Income Tax Assets |
8,370,818.39 |
| Other Non-Current Assets |
479,607.87 |
| Sub-Total of Non-Current Assets |
325,656,896.16 |
| Total Assets |
914,764,033.43 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
189,417,836.66 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
8,976,179.65 |
| Taxes Payable |
1,532,382.46 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
4,249,488.90 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,668,129.16 |
| Other Current Liabilities |
2,205,515.56 |
| Sub-Total of Current Liabilities |
223,158,124.10 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
2,373,895.30 |
| Deferred Income Tax Liabilities |
326,022.09 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
13,653,206.69 |
| Total Liabilities |
236,811,330.79 |
| Paid-In Capital(Or Share Stock) |
132,000,000.00 |
| Capital Surplus |
195,378,661.97 |
| Surplus Reserve |
40,091,482.89 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
310,366,745.82 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
677,952,702.64 |
| Owner's Equity（Stockholder's Equity） |
677,952,702.64 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
914,764,033.43 |
